<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[antibiotic Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/antibiotic.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to antibiotic]]></description>
	<s:counts start="0" returned="20" found="43" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Generic Threat to Optimer Pharma's Fidaxomicin Antibiotic]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10003960/generic-threat-to-optimer-pharmas-fidaxomicin-antibiotic/]]></link>
		<description><![CDATA[The relative efficacy of Optimer Pharma's investigational antibiotic, fidaxomicin, compared to standard-of-care vancomycin marketed as Vancocin by drugmaker ViroPharma, remains unclear. Even if Optimer obtains regulatory approval to market fidaxomicin, its commercial success will be limited by the likely appearance of generic vancomycin. by David Phillips]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 28 Aug 2009 12:08:28 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[Antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/david+phillips.html"><![CDATA[David Phillips]]></category>
	</item>
	<item>
		<title><![CDATA[British researchers develop new drug - with maggots]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200808/ai_n27973714]]></link>
		<description><![CDATA[LONDON AFP &#8212; British researchers have developed a new antibiotic using maggots which can be used to treat bugs including some strains of the drug-resistant bacteria MRSA, they announced Tuesday.  The team from Swansea University in south Wales has created Seraticin, a drug made from the secretions of green...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 05 Aug 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/researcher.html"><![CDATA[researcher]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Novartis buys Protez for rights to new antibiotic]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200806/ai_n25477967]]></link>
		<description><![CDATA[BASLE, Switzerland AFP &#8212; Swiss pharmaceutical giant Novartis announced on Wednesday it had bought Protez Pharmaceuticals for 100 million dollars (64.8 million euros), thus acquiring the rights to a new antibiotic.  The initial 100-million-dollar payment could be followed by up to another 300 million depending on the performance of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 04 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Purdue Center Takes on North American Battle Against Multidrug-Resistant Tuberculosis]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Dec_13/ai_n27474163]]></link>
		<description><![CDATA[WEST LAFAYETTE, Ind. -- Multidrug-resistant tuberculosis has a new challenger, a center in the Purdue Research Park that became the sole North American producer of a potent antibiotic.  The drug, Seromycin[R], had been developed earlier by Eli Lilly and Co., which, in turn, gave the park's Chao Center for...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 13 Dec 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/world+health+organization.html"><![CDATA[World Health Organization]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[ADVANCED LIFE SCIENCES TO STUDY CETHROMYCIN FOR ANTHRAX.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6494/is_200710/ai_n25837088]]></link>
		<description><![CDATA[Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), Chicago, has  announced the commencement of its collaboration with the National  Institute of Allergy and Infectious Diseases NIAID, the lead  governmental institute supporting biodefense research, under which the  NIAID will conduct studies to evaluate cethromycin, the company's  late-stage...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 01 Oct 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/collaboration.html"><![CDATA[Collaboration]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/groupware.html"><![CDATA[Groupware]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/infection.html"><![CDATA[infection]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+government.html"><![CDATA[U.S. Government]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Nigeria files new lawsuit against Pfizer]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200707/ai_n19379958]]></link>
		<description><![CDATA[ABUJA AFP &#8212; Nigeria filed a new lawsuit Friday against US pharmaceutical giant Pfizer claiming some 6.5 billion dollars in damages for deaths allegedly stemming from drug trials.  Hours after dropping its original suit claiming seven billion dollars in damages, government lawyer Babatunde Irukera presented a new complaint to...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 20 Jul 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/lawsuit.html"><![CDATA[lawsuit]]></category>
		<category domain="http://resources.bnet.com/topic/lawyer.html"><![CDATA[lawyer]]></category>
		<category domain="http://resources.bnet.com/topic/nigeria.html"><![CDATA[Nigeria]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[U of Florida patents antimicrobial peptide]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3042/is_1_43/ai_n29243502]]></link>
		<description><![CDATA[* Patent No. US 6,964,760 B2: The University of Florida Research Foundation, Gainesville, FL has patented an antimicrobial polypeptide, nucleic acid and their methods of use. The isolated antibiotic comprises SEQ ID NO:6.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 01 Jan 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+florida.html"><![CDATA[University of Florida]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[In Vitro Study Results Show Ceragenix's Lead Antibiotic Compound Has Greater Bactericidal Activity against Potentially Lethal Bacterial Infections Than Leading Commonly-Prescribed Antibiotic Treatments]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Dec_21/ai_n15955853]]></link>
		<description><![CDATA[DENVER -- Studies presented at the 45th Interscience Conference of Antimicrobial Agents and Chemotherapy ("ICAAC") demonstrated that Ceragenix Pharmaceuticals, Inc.'s ("Ceragenix" or the "Company") (OTCBB: CGXP) investigational antibacterial CSA-13 showed an excellent microbiology profile in laboratory studies against vancomycin resistant staph aureus ("VRSA"), vancomycin intermediate resistant staph aureus strains ("VISA"),...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 21 Dec 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/infection.html"><![CDATA[infection]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Vietnam seafood body protests sales ban in US southern states]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200508/ai_n14901937]]></link>
		<description><![CDATA[HANOI AFP &#8212; Vietnam's seafood industry body protested against the decision of some southern US states to suspend the sale of Vietnamese basa catfish fillet products citing the presence of an antibiotic.  The states were reported to have taken the action after some samples of the farmed product imported...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 24 Aug 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[SALES]]></category>
		<category domain="http://resources.bnet.com/topic/vietnam.html"><![CDATA[Vietnam]]></category>
		<category domain="http://resources.bnet.com/topic/vietnamese.html"><![CDATA[Vietnamese]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Keep Antibiotics Working Praises FDA's First Ever Ban ofAgricultural Drug Due to Antibiotic-Resistance Effects in Humans]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200507/ai_n21855978]]></link>
		<description><![CDATA[WASHINGTON, July 28 /U.S. Newswire/ -- The Keep Antibiotics Working KAW coalition commended newly confirmed U.S. Food and Drug Administration FDA Commissioner Lester Crawford for today issuing a precedent-setting, final decision to withdraw approval fWASHINGTON, July 28 /U.S. Newswire/ -- The Keep Antibiotics Working KAW coalition commended newly confirmed U.S....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 28 Jul 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Medical Groups Petition FDA to Ban Antibiotics as Feed Additives Citing Noncompliance with FDA Guidance to Protect Human Health]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200504/ai_n21851669]]></link>
		<description><![CDATA[WASHINGTON, April 7 /U.S. Newswire/ -- Five major medical and environmental groups today filed a formal regulatory petition with the U.S. Food and Drug Administration FDA urging the agency to withdraw approvals for seven classes of antibiotics for use aWASHINGTON, April 7 /U.S. Newswire/ -- Five major medical and environmental...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 07 Apr 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/petition.html"><![CDATA[petition]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Promising new antibiotic for TB]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200412/ai_n8605376]]></link>
		<description><![CDATA[WASHINGTON AFP &#8212; A new antibiotic may speed up treatment of tuberculosis, the most deadly infectious disease in the world after AIDS, drugmaker Johnson and Johnson announced.  The treatment, tested in mice, appeared to be safe in a preliminary study in healthy humans, the drugmaker said.  "Scientists at...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 09 Dec 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[HARDWARE]]></category>
		<category domain="http://resources.bnet.com/topic/infection.html"><![CDATA[infection]]></category>
		<category domain="http://resources.bnet.com/topic/mice.html"><![CDATA[Mice]]></category>
		<category domain="http://resources.bnet.com/topic/mouse.html"><![CDATA[mouse]]></category>
		<category domain="http://resources.bnet.com/topic/scientist.html"><![CDATA[scientist]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Group Representing 9 Million Consumers Objects to New USDA Directive that Weakens Organic Standards]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200404/ai_n21832771]]></link>
		<description><![CDATA[Keep Antibiotics Working: The Campaign to End Antibiotics Overuse ( http://www.KeepAntibioticsWorking.com ), is a coalition of health, consumer, agricultural, environmental, humane and other advocacy groups with more than nine million members dedicated toKeep Antibiotics Working: The Campaign to End Antibiotics Overuse ( http://www.KeepAntibioticsWorking.com ), is a coalition of health, consumer,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 30 Apr 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+agriculture.html"><![CDATA[U.S. Department of Agriculture]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Books: Leisure reading]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4188/is_20040402/ai_n11448923]]></link>
		<description><![CDATA['Loud and Clear'   By Anna Quindlen   Random House, $24.95.   Anna Quindlen, who left her job as a New York Times columnist to become a novelist, is still writing columns, currently for Newsweek. And they are very good. She is also writing novels -- and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 02 Apr 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/books.html"><![CDATA[Books]]></category>
		<category domain="http://resources.bnet.com/topic/clear.html"><![CDATA[Clear]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/mold.html"><![CDATA[mold]]></category>
		<category domain="http://resources.bnet.com/topic/mortgages.html"><![CDATA[Mortgages]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Ronald McDonald says no.(McDonald's Corp.)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5047/is_200401/ai_n18337754]]></link>
		<description><![CDATA[One of your New Year's resolutions this year may be to figure  out how--or if--you can produce meat without the use of growth-promoting  antibiotics. The world's largest buyer of agricultural products  worldwide, McDonald's, announced it wants to phase   One of your New Year's resolutions this...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 Jan 2004 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/mcdonald%2527s+corp..html"><![CDATA[McDonald's Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MCD</category>
		<category domain="tickers">MCD</category>
	</item>
	<item>
		<title><![CDATA[Mutant clue opens up new front against cystic fibrosis]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200311/ai_kepm354702]]></link>
		<description><![CDATA[PARIS AFP ? Experts believe they have found a molecular chink in the crippling lung disease known as cystic fibrosis, the British journal Nature reports.  An inherited disease, cystic fibrosis is a disorder in which the lungs become clogged with a thick, gluey mucus inhabited by a bacterium, Pseudomonas...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 19 Nov 2003 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Genome Therapeutics and Genesoft Pharmaceuticals Announce Definitive Merger Agreement]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2003_Nov_18/ai_n27680320]]></link>
		<description><![CDATA[Business Editors/Health/Medical Writers  BIOWIRE2K  NOTE TO MEDIA:  Multimedia assets available  A slideshow will be available at a later time  WALTHAM, Mass. & SAN FRANCISCO--BUSINESS WIRE--Nov. 18, 2003  Merged Companies Combine Expertise to Create Leading  Anti-Infectives Biopharmaceutical Company  Launch of FDA-Approved FACTIVER (gemifloxacin...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 18 Nov 2003 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/board.html"><![CDATA[board]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/genome.html"><![CDATA[genome]]></category>
		<category domain="http://resources.bnet.com/topic/infection.html"><![CDATA[infection]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/merger.html"><![CDATA[merger]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/rash.html"><![CDATA[Rash]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[HHS, Public Health Partners Unveil New Campaign to Promote Awareness of Proper Antibiotic Use]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200309/ai_n21824265]]></link>
		<description><![CDATA[WASHINGTON, Sept. 17 /U.S. Newswire/ -- The Department of Health and Human Services and a consortium of national health organizations today urged consumers to be cautious about their use of antibiotics as the cold and flu season approaches. Officials streWASHINGTON, Sept. 17 /U.S. Newswire/ -- The Department of Health and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 17 Sep 2003 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/cold.html"><![CDATA[cold]]></category>
		<category domain="http://resources.bnet.com/topic/flu.html"><![CDATA[flu]]></category>
		<category domain="http://resources.bnet.com/topic/public+health.html"><![CDATA[public health]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+health+and+human+services.html"><![CDATA[U.S. Department of Health and Human Services]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[WHO report promotes reduction in levels of livestock antimicrobials.(News)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200308/ai_n13359717]]></link>
		<description><![CDATA[IN ANOTHER strike against the market for growth-promoting  antibiotics, the World Health Organization WHO has released a report  that supports reducing the levels of antibiotics used in livestock.       The WHO report examines the consequences of a     IN ANOTHER...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 18 Aug 2003 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/livestock.html"><![CDATA[livestock]]></category>
		<category domain="http://resources.bnet.com/topic/world+health+organization.html"><![CDATA[World Health Organization]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[McDonald's calls for phaseout of growth promoters. (Markets: Pharmaceuticals & Fine Chemicals).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200306/ai_n13187347]]></link>
		<description><![CDATA[IN A POTENTIALLY trendsetting move, the country's largest  purchaser of beef and a major user of chicken, beef and pork is asking  suppliers to stop using a number of antibiotics as growth promoters.  McDonald's Corp., which buys over 2.5 billion poun    IN A POTENTIALLY...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 30 Jun 2003 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/antibiotic.html"><![CDATA[antibiotic]]></category>
		<category domain="http://resources.bnet.com/topic/beef.html"><![CDATA[beef]]></category>
		<category domain="http://resources.bnet.com/topic/mcdonald%2527s+corp..html"><![CDATA[McDonald's Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MCD</category>
		<category domain="tickers">MCD</category>
	</item>
</channel>
</rss>
